Neurocognitive functioning after carotid revascularization: a systematic review by Plessers, Maarten et al.
 © 2014 S. Karger AG, Basel
1664–5456/14/0042–0132$39.50/0 
 Review 
 Cerebrovasc Dis Extra 2014;4:132–148 
 Neurocognitive Functioning after 
Carotid Revascularization: A Systematic 
Review 
 Maarten Plessers a    Isabelle Van Herzeele b    Frank Vermassen b    
Guy Vingerhoets a 
 a  Department of Experimental Psychology, Ghent University, and  b  Department of Thoracic 
and Vascular Surgery, Ghent University Hospital,  Ghent , Belgium
 
 Key Words 
 Cognitive outcome · Carotid endarterectomy · Carotid artery stenting · Systematic review · 
Carotid revascularization · Neuropsychology 
 Abstract 
 Background: The objective of this study was to review the recent literature regarding the 
neurocognitive consequences of carotid endarterectomy (CEA) and carotid stenting (CAS). 
 Methods and Results: A PubMed and Web of Science search was conducted using the key 
words ‘carotid’ in combination with ‘cognitive’, ‘cognition’, ‘neurocognition’, ‘neurocognitive’, 
‘neuropsychology’, and ‘neuropsychological’. Bibliographies of relevant articles were cross-
referenced. We included 37 studies published since 2007 of which 18 examined CEA, 12 CAS, 
and 7 compared CEA to CAS. There is a wide variability in the reported neurocognitive out-
come following CEA and CAS. Nonetheless, none of the included studies unveiled significant 
differences between CEA and CAS on postoperative neurocognitive functioning. Postopera-
tive changes observed for CEA and CAS separately seem limited to a small percentage (around 
10–15%) of patients and can either present as an improvement or impairment.  Key Messages: 
The available data seem to suggest that no obvious cognitive differences between CAS and 
CEA can be observed after intervention. Both improvement and deterioration in cognitive 
functioning can be observed following CAS or CEA. Methodological differences such as pa-
tient heterogeneity, implementation and type of control groups, type of psychometric tests 
used, statistical analyses, or timing of the assessments play an important role in explaining 
the sometimes divergent results of the included studies. Large-scale and methodologically 
solid studies comparing CEA and CAS on neurocognitive outcome remain warranted. Future 
studies should implement adequate control groups to correct for practice effects in the target 
groups.  © 2014 S. Karger AG, Basel 
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 Introduction 
 Stroke is the third leading cause of death in most western countries  [1] . Carotid stenosis 
has been identified as a risk factor for stroke, with increasing risk depending on the severity 
of the stenosis  [2] . The prevalence of carotid stenosis increases with age in both men and 
women  [3] and with increasing life expectancy, this problem tends to become more 
important.
 To reduce the risk of stroke, carotid endarterectomy (CEA) is performed and has shown 
to be effective in reducing stroke in patients with recent carotid territory symptoms  [4] as 
well as in asymptomatic patients  [5] . Since CEA reduces stroke risk by half in asymptomatic 
patients  [5] , CEA is carried out regularly, although the debate whether asymptomatic patients 
on appropriate medical treatment should be treated is still ongoing  [6] .
 Carotid artery stenting (CAS) has been suggested to be an alternative for CEA, especially 
in high-risk patients, reducing cranial nerve injury, wound complications and the possible 
negative effects of general anesthesia such as myocardial infarction  [7] . The use of prophy-
lactic CEA and CAS has been evaluated in many studies, and both methods are safe and 
effective options for stroke prevention in appropriately selected patients and if treated by 
proficient surgeons or endovascular therapists  [8–10] .
 Although CREST has suggested that CAS is deemed noninferior to CEA on traditional 
combined endpoints of stroke, myocardial infarction, and death  [8] , it is associated with an 
increased risk of new lesions on diffusion-weighted imaging (DWI) in comparison to CEA  [11, 
12] . Therefore, other outcome variables like neurocognitive functioning (NCF) should also be 
studied to evaluate the impact of these lesions in the long term  [13] . Any carotid revascular-
ization may lead to cognitive decline caused by procedural emboli, general anesthesia (CEA), 
or temporary flow interruption [clamping (CEA) or balloon dilatation (CAS)]  [13, 14] . 
Conversely, reopening a stenotic vessel and restoring blood flow to the brain may improve 
cognitive dysfunction caused by chronic hypoperfusion  [13, 14] . To date, it is still unclear 
whether these complex interactions ultimately result in a net improvement or a deterioration 
in the cognitive function  [15] .
 Several systematic reviews about NCF after carotid revascularization have been published 
in 2007 and 2008  [14, 16, 17] . The consensus was that it was unclear whether carotid revas-
cularization results in cognitive decline, improvement, or no change at all. It was stated that 
further research is necessary to clarify the effects of CEA and CAS.
 Several factors may contribute to this inconsistency. First, there is much variability in the 
demographical and clinical characteristics of patients, such as differences in symptoms (i.e. 
presence or absence of stroke), baseline cerebral perfusion status, age, sex, education, profes-
sional level, side and severity of stenosis, length of time between symptoms and revascular-
ization, and medical, neurological and psychiatric histories  [17] . Second, study characteristics 
also vary widely, in particular the susceptibility of the design to learning and practice effects, 
type of tests used (and their inherent sensitivity), timing of assessments, and failure to 
implement a (decent) control group. Other factors, like underpowered studies, and variability 
of surgical techniques and criteria in detecting postoperative change also flaw these cognitive 
studies  [14, 16] .
 For this review, we will only include papers published since 2007 for two reasons. First, 
studies published before 2007 have already been discussed extensively in former reviews 
while no systematic overview of the recent literature has been reported since 2008. Second, 
because carotid treatment, including medical equipment (e.g. protection devices for CAS and 
type of stents used), and drug therapy tend to continuously evolve, it is important to look at 
the recent papers for a better ecological validity of the findings. Indeed, there seems to be a 
difference between the results of publications depending on the date of publication  [14, 17] , 
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where older studies have a higher chance of finding positive results. As De Rango et al.  [14] 
suggested, this might be the consequence of fewer methodological biases in more recent 
studies.
 We will conclude our review with some methodological remarks about research on the 
cognitive consequences of carotid revascularization and formulate some guidelines that may 
be relevant for future research.
 Methods 
 In this systematic review, we focus on the neurocognitive consequences of carotid revas-
cularization. We included all English papers concerning the topic of cognitive effects of carotid 
revascularization published between 2007 and May 2013. Searches were conducted on 
PubMed and Web of Science using the key word ‘carotid’ in combination with ‘cognitive’, 
’cognition’, ‘neurocognition’, ‘neurocognitive’, ‘neuropsychology’, and ‘neuropsychological’. 
References of included papers were cross-checked for other relevant papers. Only papers 
investigating the effects of carotid revascularization (CEA and CAS) on the cognitive functions 
were retained; reviews were excluded. Papers were included when neurocognitive testing 
was carried out preoperatively and at least once postoperatively more than 5 days after 
carotid treatment. Studies that only examined the cognitive functions on the first postoper-
ative days were excluded because anesthesia and type of postoperative medical care may 
heavily influence these short-term results. Indeed, by using event-related potentials, Mracek 
et al.  [18] found that general anesthesia had a negative effect on cognition the first postop-
erative day, but after 6 days no differences in cognitive functions were noted between general 
and local anesthesia.
 To ensure that studies conducted extensive neuropsychological testing, papers that only 
used cognitive screening instruments, such as the Mini-Mental State Examination (MMSE), 
were excluded. Furthermore, when in total less than 15 patients adhered to follow-up, we 
excluded the study to avoid underpowering. Finally, studies that solely investigated the 
effects of revascularization of carotid occlusions were also excluded, since it may not be 
possible to extrapolate these results to nonocclusive significant carotid artery stenoses.
 Studies were grouped into three categories: CEA alone, CAS alone, and CEA versus CAS. 
Results in these three categories are reviewed for common findings; a focus is given on 
papers with solid methodological setups, such as studies using the reliable change indices 
by calculating z-scores: (individual test score – mean score of control group)/SD of control 
group. When simply comparing pre- and postrevascularization cognitive scores for both 
patient and control groups separately, results are heavily influenced by characteristics like 
sample size in both groups. Studies are given a superscript ‘a’ mark when they included a 
control group and compared the patient group(s) with this control group using statistical 
methods. A superscript ‘b’ mark was given when they included an adequately sized control 
group but did not compare the groups with each other directly. Underpowered control 
groups were defined as sample sizes of less than half of the patient sample size. Studies 
received a superscript ‘c’ mark when they did not implement a control group, or when they 
did but did not compare the groups directly, and when the control group contained less than 
half the amount of subjects in the patient group. All CEA versus CAS studies were reviewed 
because they have at least two groups, which allows a valid comparison between the two 
techniques. Of the studies only examining CEA or CAS, only studies that received a super-
script ‘a’ or ‘b’ mark were reviewed in the Results section to ensure the focus is given on 
methodologically sound studies.
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 Results 
 Sixty-seven studies were identified, of which 37 were included in this review. The papers 
excluded were 5 reviews, 5 having a too small sample size in follow-up assessments, 6 only 
using short screening instruments (MMSE), 1 missing a preoperative assessment, 9 only 
providing follow-up data for a few days, and 2 focusing on intragroup differences and not 
reporting results of the whole group. Of the 39 remaining articles, 1 study  [19] was also 
excluded because of a large variation in the timing of the postoperative assessment. Patients 
were tested between 4 and 41 months after intervention. Since the timing of postoperative 
testing can also be a confounding factor, results from this study are impossible to interpret 
and to compare with other studies. Another study  [20] was left out of this review because it 
was a subgroup analysis of another paper already included  [21] . So in total, 37 studies were 
included in this review of which 11, 4, and 22 received the superscript ‘a’, ‘b’, and ‘c’ mark, 
respectively.
 Studies Comparing Neurocognitive Outcome after CEA versus CAS 
 Five of the 7 studies comparing CEA with CAS found no significant differences in cognitive 
outcome between procedures  [7, 22–25] ( table 1 ). Lal et al.  [13] also found no differences in 
the global cognitive score, but discovered that CEA resulted in a reduction in memory perfor-
mance compared with CAS, while CAS patients showed reduced psychomotor speed. Wasser 
et al.  [21] also found no significant differences in the global difference score, but the domain 
verbal learning showed a small improvement for CAS compared with CEA.
 Although this review contains 2 studies focusing on symptomatic, 2 on asymptomatic, 
and 3 on symptomatic as well as asymptomatic patients, and some studies even randomized 
the patients to CEA and CAS, all these studies concluded that CAS and CEA have a comparable 
effect on cognition in asymptomatic and symptomatic patients.
 When looking at the results for CAS and CEA separately compared to healthy controls and 
applying the methodological criteria described previously, only 2 of the 7 studies are eligible 
and both used an extensive neuropsychological test battery ( table 1 ; 2 studies with a super-
script ‘a’ mark). Wasser et al.  [21] found that both patients after CAS and after CEA deterio-
rated significantly over time in the domain short-term memory and in visuoconstructive 
functions compared to controls. Altinbas et al.  [22] found for CAS, but not for CEA, a small but 
significant decrease in the total cognitive sum score.
 Studies on Neurocognitive Outcome following CEA 
 Eleven  [26–36] of the 18 studies  [26–43] examining the effects of CEA fulfilled our criteria 
( table 2 ; 8 studies with a superscript ‘a’ mark and 3 with a superscript ‘b’ mark). The 
Department of Neurosurgery of the Iwate Medical University published several papers on the 
cognitive consequences of CEA, all using established tests of intelligence and memory. Studies 
that examined cognitive deterioration found impairment in 13% of patients after CEA  [27, 
30] , while studies focusing on cognitive amelioration after CEA found improvement in 10% 
of the cases  [28, 29] . One study evaluated both trends and noted improvement in 10% and 
impairment in another 10% of the patients in one or more cognitive domains. All these stud-
ies thus found comparable results.
 However, other research groups found no changes over time for the patient group  [34] , 
while Baracchini et al.  [35] found slight but significant improvements in symptomatic but not 
in asymptomatic patients. It is important to note though that the latter study showed baseline 
differences between the symptomatic and asymptomatic groups. Gigante et al.  [33] noted a 
decrease in cognitive score in 6% of CEA patients while Yocum et al.  [32] discovered a decrease 
in 16% of patients.
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Reference Patients in 
follow-up
Control 
group 
Follow-up 
period
NCF after CEA versus CAS Control for effect 
of previous 
stroke on NCF
Cognitive domains and tests 
Witt et al. 
[7], 2007c 
45 
24 CEA vs. 21 CAS 
without CPD
Randomized
Sympt.
No 6 and 30 
days
No differences between CEA and CAS 
at 6 or 30 days
At 6 days: 
Decline in 19% of CEA vs. 21% of CAS
Improvement in 25% of CEA vs. 14% 
of CAS in 2 or more tasks
At 30 days:
Decline in 25% of CEA vs. 24% of CAS 
Improvement in 29% of CEA vs. 24% 
of CAS in 2 or more tasks
CAS: 33% stroke 
CEA: 50% stroke 
No differences in 
frequency stroke 
between groups
Verbal memory: RAVLT
Non-verbal memory: CFT-R
Attention: Paced Visual Serial 
Addition Test, TMT (A and B), 
Modified Stroop 
Executive function: verbal 
fluency (phonologic and 
semantic), RNGT
Motor skills: Purdue Pegboard 
Test, Finger-Tapping Test
Takaiwa et 
al. [23], 
2009c
26 
11 CEA vs. 15 CAS 
with CPD
No randomization
Asympt. + sympt. 
(45% CEA, 60% 
CAS) 
No 1 week,
3, 6, and 
12 months
No significant differences between 
CEA and CAS for any of the domains 
or MMSE 
Only CEA showed decrease at 1 week
At 1 week: 
CEA: 36% of patients showed 
decrease for immediate as well as 
delayed memory, visuospatial 
construction, language, and total 
score
CAS: 13% showed decrease for 
visuospatial construction and 
language / 36% showed improvement 
for immediate and delayed memory, 
and total score 
At 3, 6, and 12 months: 
Improvement in 54% of CEA vs. 67% 
of CAS
No deterioration
No differences in 
frequency 
symptomatic 
status between 
groups
MMSE
RBANS (immediate memory, 
visuospatial construction, 
language, attention, delayed 
memory, and total score)
Feliziani 
[24], 
2010c
46 
22 CEA vs. 24 CAS 
with CPD
No randomization
Asympt. 
No 3 and 
12 months
No significant differences between 
the groups over time for all studied 
variables
No changes over time for CEA or CAS, 
except for a slight deterioration in 
visuospatial construction in the CAS 
group
NA MMSE 
Memory: Babcock Story Recall, 
RAVLT, semantic fluency
Attention and executive 
functions: TMT (A and B), 
COWAT
Visuospatial construction: Copy 
Drawing Test
Altinbas 
et al. [22], 
2011a 
119 
58 CEA vs. 61 CAS 
(no info about CPD)
Randomized
Sympt. 
75
healthy 
(historical 
control)
6 months No significant differences between 
CEA and CAS in any of the domains
No changes in any of the 6 domains 
for CAS or CEA
A small but significant decrease in 
cognitive sum score for CAS, but not 
for CEA 
CAS: 42% stroke 
CEA: 51% stroke
No differences in 
frequency stroke 
between groups 
NRT, MMSE
Abstract reasoning: WAIS-III 
similarities, RAPM
Attention: WAIS-III digit span 
(f), Visual Elevator of the Test 
of Everyday Attention
Executive functioning: BSAT, 
letter fluency
Language: TT, BNT
Verbal memory: WAIS-III digit 
span (b), RAVLT, semantic 
fluency
Visual memory: CFT-R
Visual perception: JLO, FRT, 
CFT-R (copy)
Neglect: Star Cancellation Test
Lal et al. 
[13], 
2011c
46
25 CEA vs. 21 CAS 
with CPD
No randomization
Asympt.
No 4 – 6 
months
No differences on composite change 
score for CEA and CAS. Both groups 
showed improvement on composite 
change score and each individual test
Impairment only observed in CEA for 
working memory index and CAS for 
psychomotor speed. No differences 
between CEA and CAS on other tests
NA TMT 
Processing speed index (digit 
symbol coding and symbol 
search) of WAIS-III 
Working memory index (letter-
number sequencing and spatial 
span) of WAIS-III 
BNT 
COWAT 
HVLT
 Table 1.  Studies comparing neurocognitive outcome after CEA versus CAS
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 In the studies comparing patient groups with control groups separately, Czerny et al.  [36] 
found an improvement over time for the patient group on the Number Connection Test at 1 
year but not after 5 years. At 1 month after intervention, Soinne et al.  [31] observed NCF 
impairment in 11% of CEA patients but in 0% of the controls. 
 We can summarize that in most studies, a decrease in the cognitive score over time is 
found in 10–15% of patients after CEA. Improvements are also often observed in about 10% 
of patients. 
 Studies on Neurocognitive Outcome after CAS 
 Only 2  [44, 45] of the 12  [44–55] included studies examining the effects of CAS fulfilled 
our methodological criteria regarding control groups ( table 3 ; 1 study with a superscript ‘a’ 
mark and 1 with a superscript ‘b’ mark). Xu et al.  [45] implemented a relevant control group 
that underwent a carotid angiography to correct for practice effects. They used an extensive 
neuropsychological battery. Only verbal memory showed better results over time in the CAS 
group; no deterioration in the other tests was observed. Ishihara et al.  [44] did not use a 
reliable change index to measure differences over time in the CAS group, but they had two 
different control groups. They found differential effects for right-sided CAS (improvement in 
performance IQ and delayed memory) and left-sided CAS (improvement in verbal IQ). The 
first control group undergoing neck clipping through craniotomy had minor but nonsignif-
icant increases in the Wechsler Adult Intelligence Scale (third edition) and the Wechsler 
Reference Patients in 
follow-up
Control 
group 
Follow-up 
period
NCF after CEA versus CAS Control for effect 
of previous 
stroke on NCF
Cognitive domains and tests 
Wasser 
[21], 
2011a
55 
31 CEA vs. 24 CAS 
(CPD in 9 of 24)
No randomization
Asympt. + sympt. 
(71% CAS, 39% 
CEA) 
27 healthy 
Matched 
(age and 
education)
3 months No significant differences between 
the groups on 5 of the 6 domains. 
Only verbal learning showed an 
improvement for CAS whereas CEA 
showed deterioration
Both groups deteriorated significantly 
over time in the domain of short-term 
memory, and visuoconstructive 
functions
CEA: 16% stroke 
CAS: 30% stroke
No differences in 
frequency stroke 
between groups
MMSE
Attention: TAP (alertness and 
divided attention) 
Short-term memory: TAP 
(working memory), SRT, 
WMS-R
Executive functions: RWFT, 
WCST, Regard’s Five Point Test
Verbal learning and memory: 
SRT, WMS-R,
Non-verbal learning and 
memory: CFT-R (recall), lNVLT, 
Spatial Recall Test
Visuoconstructive functions: 
CFT-R (copy)
Zhou et al. 
[25], 
2012c
51 
35 CEA vs. 16 CAS 
with CPD
No randomization
Asympt. + sympt. 
(54% CEA, 50% 
CAS) 
No 1 month No differences between the groups on 
test sco res
No statistical methods were used to 
evaluate cognitive impairment or 
improvement
CEA: 20% stroke
CAS: 25% stroke 
No differences in 
frequency stroke 
between groups
ART
MMSE
Memory: RAVLT
Attention and executive 
function: TMT, Digit Span, 
color-word interference 
Language: category fluency, 
BNT, 
Motor skills: GP
(no information about results of 
tests in italics)
 Author names in bold means the study was reviewed in the Results section. NA = Not applicable; CPD = cerebral protection device; WAIS-III = Wechsler Adult 
Intelligence Scale, third edition; WMS-R = Wechsler Memory Scale Revised; CFT-R = Rey Complex Figure Test; RAVLT = Rey Auditory Verbal Learning Test;
HVLT = Hopkins Verbal Learning Test; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; GP = Grooved Pegboard; RWFT = Regens-
burger Word Fluency Test; NVLT = Non-Verbal Learning Test; SRT = Selective Reminding Test; TAP = Test Battery for Attentional Performance; JLO = Judgement 
of Line Orientation; RNGT = Random Number Generation Task; FRT = Facial Recognition Task; RAPM = Raven Advanced Progressive Matrices; TT = Token Test; 
BSAT = Brixton Spatial Anticipation Task; TMT = Trail Making Test; COWAT = Controlled Oral Word Association Test; BNT = Boston Naming Test; WCST = Wisconsin 
Card Sorting Test; ART = Adult Reading Test.
a Using statistical methods to compare the patient and control group. c No control group, or calculating differences for the patient and control group over time 
separately, with a control group that contains less than half the number of the patient group.
Table 1 (continued)
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Reference Patients in 
follow-up
Control group Follow-up 
period
NCF after CEA Control for effect 
previous stroke on 
NCF
Cognitive domains and tests
Bossema et 
al. [34], 
2007a
45 CEA 
(20 lCEA and 
25 rCEA)
Asympt. + 
sympt. (lCEA: 
45%, rCEA: 
76%)
25 healthy 
(similar 
education, age, 
and hand 
dominance) 
3 months No interactions between time 
and group. Both groups 
improved equally 
No difference between 
patients and controls on 
reliable changes after CEA
No stroke included Dichotic Listening Test
Finger Tapping Test
Motor Planning Test / Verbal 
Fluency Test (COWAT + category)
Doors Test
Saito et al. 
[39], 2007c
55 CEA
Asympt. + 
sympt. (62%)
20 patients 
(neck clipping 
through 
craniotomy)
1 month Impairment: 11% in one or 
more cognitive domains (only 
impairments were assessed)
44% stroke
No symptoms <1 
month 
No significant 
differences between 
groups (impairment/
no impairment) for 
symptomatic status
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Falken-
sammer et al. 
[43], 2008c
19 CEA at 7 –
10 days
16 CEA at 6 
months
Asympt.
No 7 – 10 days,
6 months
Overall improvement at 7 – 10 
days and 6 months. 3 patients 
showed decline (1 with 
reliable change indices = 6%) 
Significant improvement in 
digit symbol, verbal memory. 
Conversely, there was a 
significant decline on one test 
assessing processing speed at 
6 months (word reading in 
SCWT)
NA Fine motor coordination: GP
Expressive language: COWAT, 
category fluency
Verbal memory: RAVLT
Mental status screen: MMSE
Estimated premorbid verbal IQ: ART
Processing speed/attention/
executive function: Digit Span and 
Digit Symbol (WAIS-R), TMT (A and 
B), SCWT, D-KEF Sorting Test
Hirooka et al. 
[38], 2008c
158 CEA
Asympt. + 
sympt. (70%) 
No 1 month Impairment: 11% on 1 or 
more of 5 domains (only 
impairments were assessed)
51% stroke 
No control for stroke 
or symptomatic status
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Chida et al. 
[27], 2009a
60 CEA
Asympt + 
Sympt (62%) 
44 patients 
(neck clipping 
through 
craniotomy; 
historical 
control)
1 month Impairment: 13% in one or 
more of 5 domains (only 
impairments were assessed)
43% stroke
No significant 
differences between 
groups (impairment/
no impairment) for 
symptomatic status
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Soinne et al. 
[31], 2009b
44 CEA
Asympt. + 
sympt. (48%) 
22 healthy 
Matched (sex, 
age, education, 
and social 
class)
100 days Equal improvement for CEA 
and controls 
At 100 days:
Impairment: CEA, 5 patients 
(11%) vs. controls, 0% 
On the domain level: attention 
48% of CEA vs. 18% of 
controls had impairment 
(significant), motor dexterity, 
32% of patients vs. 18% of 
controls (NS) 
15% minor stroke
No control for stroke 
on NCF
Language: BNT 
Verbal memory and learning: 
RAVLT
Immediate verbal memory: WAIS-R 
Digit Span –F and B
Verbal fluency: word and category 
naming
Visual memory: CFT-R – Visual 
Design Learning Test
Immediate visual memory: Corsi 
Blocks F and B
Attention: Letter Cancellation Task, 
TMT (A)
Executive function: Stroop Test, 
TMT (B)
Motor dexterity: Purdue Pegboard
Yocum et al. 
[32] (2009)a
149 CEA 
Asympt. + 
sympt. (no 
percentages 
are given)
60 patients 
(lumbar spine 
surgery)
1 month At 1 month: 
moderate to severe cognitive 
deterioration: 16% (10% 
severe, 6% moderate) 
No information is 
given about symptoms
Verbal function: BNT
Verbal fluency: COWAT
Visuospatial construction: CFT-R 
(copy)
Visuospatial memory: CFT-R (recall)
Complex conceptual switching: TMT 
(B)
Attention: TMT (A)
Verbal learning and memory: HVLT 
or BSRT 
 Table 2. Studies on neurocognitive outcome after CEA
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Reference Patients in 
follow-up
Control group Follow-up 
period
NCF after CEA Control for effect 
previous stroke on 
NCF
Cognitive domains and tests
Chida et al. 
[28], 2010a
79 CEA
Asympt. + 
sympt. (59%) 
70 healthy 1 month Improvement: 9% in one or 
more of 5 domains (only 
improvements were assessed)
19% stroke
No symptoms <2 
weeks
No significant 
differences between 
groups (improvement/
no improvement) for 
symptomatic status or 
stroke
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Czerny et al. 
[36], 2010b
25 CEA
Asympt. + 
sympt. (60%)
25 healthy 
Matched (age 
and sex)
1 and 
5 years
Improvement for patient 
group at 1 and 5 years on the 
NCT
No changes on MMSE
No stroke included MMSE 
NCT
Gigante et 
al. [33], 
2011a
127 CEA
Asympt. + 
sympt. (4%)
71 patients 
(lumbar 
laminectomy/
similar age and 
education) 
30 days At 30 days:
Moderate to severe 
deterioration: 6% 
No information is 
given about the type of 
symptoms in the 
symptomatic patients
Verbal function: BNT
Verbal fluency: COWAT
Visuospatial construction: CFT-R 
(copy)
Visuospatial memory: CFT-R (recall)
Complex conceptual switching: TMT 
(B)
Attention: TMT (A)
Verbal learning and memory: HVLT 
or BSRT
Manual dexterity: GP
Baracchini 
et al. [35], 
2012b
145 CEA
(divided into 
2 groups: 70 
asympt. and 
75 sympt.)
68 patients 
(laparoscopic 
cholecystec-
tomy) Matched 
(age and sex)
3 and 
12 months
Symptomatic: cognitive 
performance (MMSE and 
MOCA) improved
Asymptomatics: no changes 
(though baseline differences: 
symptomatics were 
significantly impaired at 
baseline, asymptomatics not)
No severe stroke 
35% of symptomatic 
group had minor 
stroke
No control for minor 
stroke on NCF
MMSE 
MOCA 
Ghogawala et 
al. [37], 
2012c
23 CEA (at 1 
month)
20 CEA at 6 
months
19 CEA at 
12 months
Asympt. + 
sympt. (21%) 
No 1, 6, and 
12 months
At 1 month: 
Improvement: 30%
Deterioration: 30 – 40% on 
TMT (A and B) and HVLT
At 12 months: significant 
improvement for all tests 
Improvement: 60% 
No stroke included Attention: TMT (A)
Executive functioning: TMT (B)
Verbal fluency: COWAT
Verbal learning and memory: HVLT
Nanba et al. 
[30], 2012a
70 CEA 
Asympt. + 
sympt. (71%) 
44 patients 
(neck clipping 
through 
craniotomy; 
historical 
control)
1 month Deterioration: 13% in one or 
more of 5 domains (only 
impairments were assessed)
31% stroke
No symptoms <2 
weeks
No significant 
differences between 
groups (impairment/
no impairment) for 
symptomatic status 
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Yamashita 
et al. [29], 
2012a
140 CEA
Asympt. + 
sympt. (69%) 
70 healthy 
(historical 
control)
1 month Improvement in 10% of 
patients in one or more of 5 
domains (only improvements 
were assessed)
No symptoms <2 
weeks
No significant 
differences between 
groups (improvement/
no improvement) for 
symptomatic status 
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Yosida et al. 
[40], 2012c 
213 CEA
Asympt. + 
sympt. (65%) 
40 healthy 1 – 2 
months 
Improvement: 13%
Deterioration: 12%
No symptoms <2 
weeks
No control for stroke 
on NCF
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall)
Inoue et al. 
[41], 2013c
81 CEA
Asympt. + 
sympt. (54%) 
No 6 months Significant improvement for 
all scores (VIQ, PIQ, 
WMS-memory and 
WMS-attention)
No information about 
stroke tendency of 
positive effect of 
symptomatic status on 
progress
WAIS-R (verbal IQ + performance 
IQ)
WMS (memory + attention)
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Memory Scale scores. The second control group with atherosclerotic disease had no changes 
over time, but this was a smaller group and thus had lower statistical power. Though there 
are only 2 studies, methodologically solid enough to draw conclusions, small, but positive 
results are found over time for CAS patients. The problem of the lack of methodologically solid 
studies can also be observed in the review of De Rango et al.  [14] . Only few studies have been 
published investigating the cognitive consequences of CAS, and even fewer have recruited a 
control group.
 Additional Findings 
 Symptomatic Status 
 Some papers only included asymptomatic patients, some admitted symptomatic patients 
without major (and minor) stroke, and others included all types of symptomatic patients. 
Sadly, several studies failed to provide information about the symptomatic status and type of 
symptoms in their patients. Furthermore, differences in timing between the symptoms and 
intervention can also influence the results.
 As previously stated, symptomatic status does not seem to have an influence on the 
cognitive differences or similarities found between CAS and CEA. Many studies reported no 
differences in symptomatic status or stroke between groups improving or deteriorating after 
CEA  [26–30, 39] . In contrast, Baracchini et al.  [35] found slight improvements for the symp-
tomatic but not for the asymptomatic group after CEA, though it should be noted that the 
symptomatic group showed lower baseline scores, which might explain these results. Inoue 
et al.  [41] also reported a (nonsignificant) tendency of a positive effect of symptomatic status 
on NCF after CEA. For CAS, symptomatic status also does not seem to influence cognitive 
results  [51] . Furthermore, Ortega et al.  [54] found an improvement in global cognitive score 
for patients with, as well as without, previous stroke. We can conclude that symptomatic 
status does not have a clear impact on the NCF after carotid revascularization. 
Reference Patients in 
follow-up
Control group Follow-up 
period
NCF after CEA Control for effect 
previous stroke on 
NCF
Cognitive domains and tests
Saito et al. 
[26], 2013a
100 CEA 
Asympt. + 
sympt. (64%)
40 healthy 
(historical 
control)
1 month Improvement: 10%
Impairment: 10% in one or 
more of the 5 cognitive scores 
No symptoms <2 
weeks
No significant 
differences between 
groups (improvement/
deterioration) for 
symptomatic status
WAIS-R (verbal IQ + performance 
IQ)
WMS
CFT-R (copy + recall) 
Takaiwa et 
al. [42], 
2013c
15 CEA 
Asympt.
No 3 months Improvements in immediate 
memory, attention, total scale 
of the RBANS, and 2 subtests 
of WAIS-R 
Improvement: 30% 
Deterioration: 7% in RBANS 
and WAIS-R subtest scores 
NA RBANS (immediate memory, 
visuospatial construction, language, 
attention, delayed memory, and 
total score) WAIS-R 2 subtests 
(information and picture 
completion) 
ART
Author names in bold means the study was reviewed in the Results section. NA = Not applicable; WAIS-R = Wechsler Adult Intelligence Scale Revised; WMS = 
Wechsler Memory Scale; CFT-R = Rey Complex Figure Test; RAVLT = Rey Auditory Verbal Learning Test; HVLT = Hopkins Verbal Learning Test; BSRT = Buschke 
Selective Reminding Test; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; MOCA = Montreal Cognitive Assessment; GP = Grooved 
Pegboard; NCT = Number Connection Test; TMT = Trail Making Test; COWAT = Controlled Oral Word Association Test; BNT = Boston Naming Test; ART = Adult 
Reading Test; SCWT = Stroop Color and Word Test; D-KEF = Delis-Kaplan Executive Function. 
a Using statistical methods to compare the patient and control group. b Calculating differences for the patient and control group over time separately, the control 
group contains more than half the number of the patient group. c No control group, or calculating differences for the patient and control group over time separately, 
with a control group that contains less than half the number of the patient group.
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Reference Patients in follow-up Control group Follow-up 
period
NCF after CAS Control for effect of 
previous stroke on 
NCF
Cognitive domains and 
tests
Xu et al. 
[45], 
2007a
51 CAS with CPD at 1 
week
47 CAS with CPD at 12 
weeks
Asympt. + sympt. (no 
percentages are given)
57 patients 
(carotid 
angiography)
1 and 
12 weeks
CAS patients performed better 
on the RAVLT at 1 as well as 12 
weeks 
At 1 week but not at 12 weeks, 
CAS patients showed deteri-
oration in BNT 
No stroke <1 month 
Both groups had 
similar percentage of 
stroke
RAVLT
CFT-R
BNT
Digit Span (WAIS) 
TMT 
Finger Tapping Test
MMSE
Mlekusch 
et al. [47], 
2008c
71 CAS with CPD
Asympt. + sympt. (6%)
No 6 months Significant improvement for TMT 
(A)
Improvement: 45% (at least 2 
tests)
Deterioration: 8% 
No stroke patients 
included
MMSE
Attention: TMT (A and B)
Verbal intelligence and 
fluency: COWAT + 
semantic 
Turk et al. 
[52], 
2008c
17 CAS (no info about 
CPD)
Asympt. + sympt. (76%)
No 3 months Total RBANS score, immediate 
memory and attention improved
35% stroke
No control for stroke
MMSE
RBANS
TMT
Tiemann 
et al. [49], 
2009c
22 CAS without CPD
Asympt.
No 6 weeks Improvement: LLT 
Deterioration: Digit Span 
Tendency to improvement: 
phonemic verbal fluency
Improvement: 36% 
Deterioration: 27% 
NA MWT-B, LLT,
NCT, Digit Span (F and B), 
Spatial Span (F and B)
Verbal fluency: phonolo-
gical and semantical
Block-Design-Test (WAIS)
Grunwald 
et al. [48], 
2010c
41 CAS without CPD
Asympt.
7 patients 
(endovascular 
treatment 
ACA 
aneurysms)
3 months CAS: significant increase in 
cognitive speed but not memory 
Control group: no significant 
differences
NA MMSE
Cognitive speed: NCT, 
Labyrinth Test,
Figure-Symbol Test, 
Color-Word Test
Memory: Repeat the 
Numbers Test, Word List 
Test, Image Test, Word 
Pairs Test, Symbol Test, 
Latent Learning Test
Raabe et 
al. [51], 
2010c
62 CAS with CPD (51 at 
3 months, 48 at 6 
months, and 51 at 12 
months)
Asympt. + sympt. (31%)
No 3, 6, and 
12 months
At 3 months: 
16% improvement, 82% stable, 
2% decline 
At 6 months: 
21% improvement, 71% stable, 
8% decline
At 12 months: 
22% improvement, 78% stable, 
0% decline
No major stroke
26% minor stroke
No effect of sympto-
matic status on NCF
No control for stroke
DRS-2
RAVLT
TMT (B)
ART
MMSE
Murata et 
al. [53], 
2011c
16 CAS with CPD
Sympt. 
16 healthy 1 month No differences for total score 
RBMT. No scores for control 
group are provided 
No info about stroke 
No control for stroke
RBMT 
Chen et al. 
[46], 
2012c
34 CAS with CPD 
[divided into I (n = 6): 
ipsilateral ischemia and 
failed CAS; II (n = 17): 
ipsilateral ischemia and 
successful CAS, and III 
(n =11): no ischemia 
and successful CAS]
Asympt.
No 3 months Only group II showed significant 
improvement in ADAS-cog, 
MMSE and CTM (A)
No changes for CTM (B) and 
semantic fluency 
No significant changes for groups 
I and III
NA MMSE
Alzheimer’s Disease 
Assessment Scale 
cognitive subscale 
CTM (A and B)
Semantic fluency
Mendiz et 
al. [55], 
2012c 
20 CAS with CPD
Asympt. 
No 3 months Improvement in set shifting 
(TMT B), processing speed (digit 
symbol coding and symbol 
search), and working memory 
(digit span backwards), verbal 
(RAVLT acquisition) and visual 
memory (CFT-R delayed score) 
The other tests revealed no 
differences 
NA MMSE
ACE-R
BNT 
Verbal fluency: phonologic 
and semantic
RAVLT
CFT-R
Digit Span (F and B)
TMT (A and B) 
WCST
INECO Frontal Screening, 
Digit Symbol Coding 
(WAIS-III)
Symbol Search (WAIS-III)
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 Side of Intervention 
 For CEA, the side of carotid intervention does not have an influence on cognitive function. 
By using neuropsychological instruments sensitive to hemispheric specialization, Bossema et 
al.  [34] demonstrated convincingly that changes in cognition occurred irrespective of the side 
of intervention. Similarly, Baracchini et al.  [35] detected no influence of the side of the surgery 
on any of the test variables. Furthermore, many studies found no difference in the side of inter-
vention between groups improving or groups deteriorating postoperatively  [28, 29, 39, 41] .
 In CAS, results are less consistent. Grunwald et al.  [48] and Turk et al.  [52] found no corre-
lation between the cognitive results and the side of the intervention. On the other hand, 
Ishihara et al.  [44] and Ortega et al.  [54] found differential effects for left and right CAS. 
Ishihara et al.  [44] noted that the performance IQ improved after CAS in patients with severe 
right-sided carotid artery stenosis while the verbal IQ rose after endovascular treatment of 
the left carotid artery. Ortega et al.  [54] found a significant increase in the global cognitive 
score, more specifically in language, visuospatial function, and information processing for left 
CAS, while patients with right CAS only presented a (nonsignificant) trend toward global 
cognitive improvement. 
Reference Patients in follow-up Control group Follow-up 
period
NCF after CAS Control for effect of 
previous stroke on 
NCF
Cognitive domains and 
tests
Cheng et 
al. [50], 
2013c
144 CAS (no info about 
CPD) – all MCI patients
Asympt. + sympt. (55%)
No randomization
64 MCI 
patients 
(carotid 
stenosis on 
drug therapy) 
Asympt. + 
sympt. (56%)
6 months CAS group: small but significant 
improvements in MMSE, MOCA, 
FOME  and digit span. Rapid 
verbal retrieval showed no 
significant differences
No significant changes for the 
control group 
No stroke <4 weeks
Both groups had 
similar % of stroke
MMSE
MOCA
FOME
Rapid verbal retrieval 
digit span (WAIS)
Ishihara 
et al. 
[44], 
2013b
39 (21 rCAS, 18 lCAS) 
with CPD
Asympt. + sympt. (no 
percentages are given)
2 control 
groups:
(a) 17 
patients (neck 
clipping 
through 
craniotomy), 
(b) 12 
patients 
(athero-
sclerotic 
carotid artery 
disease) 
6 months IQ performance and delayed 
memory improved after rCAS
VIQ improved after lCAS
Group A: slight but not signi-
ficant increases in most WAIS-III 
and WMS scores 
Group B: no significant changes 
in the WAIS-III or WMS scores 
No stroke <3 months
No control for stroke 
on NCF 
WAIS-III (verbal IQ, 
performance IQ, and full 
IQ) 
WMS-R (general memory, 
verbal memory, delayed 
memory, visual memory, 
attention, and concen-
tration) 
Ortega et 
al. [54], 
2013c
33 CAS with flow 
reversal
Asympt. + sympt. (50%)
No 6 months Global improvem ent, mainly 
information processing speed, 
language, memory and visuo-
spatial function
48% stroke
Global score 
improved for 
patients with and 
without previous 
stroke
Digit Span (WAIS-III), 
WMS-III Mental Control 
(attention)
BNT
Token Test
Verbal fluency: COWAT 
and Semantic Fluency
CVLT
GP
JLO
SCWT 
 Author names in bold means the study was reviewed in the Results section. NA = Not applicable; CPD = Cerebral Protection Device. WAIS-III = Wechsler Adult 
Intelligence Scale, third edition; WMS = Wechsler Memory Scale; CFT-R = Rey Complex Figure Test; RAVLT = Rey Auditory Verbal Learning Test; RBANS = Repeatable 
Battery for the Assessment of Neuropsychological Status; MOCA = Montreal Cognitive Assessment; GP = Grooved Pegboard; NCT = Number Connection Test;
RBMT = Rivermead Behavioral Memory Test; CVLT = California Verbal Learning Test; JLO = Judgement of Line Orientation; FOME = Fuld Object Memory Evaluation; 
CTM = Color Trail Making Test; ACE-R = Addenbrooke’s Cognitive Examination Revised; LLT = List Learning Test; TMT = Trail Making Test; COWAT = Controlled 
Oral Word Association Test; BNT = Boston Naming Test; WCST = Wisconsin Card Sorting Test; ART = Adult Reading Test; SCWT = Stroop Color and Word Test; 
MWT-B = Mehrfach-Wahl-Wortschatz-Test; ACA = anterior cerebral artery. 
a Using statistical methods to compare the patient and control group. b Calculating differences for the patient and control group over time separately, the control 
group contains more than half the number of the patient group. c No control group, or calculating differences for the patient and control group over time separately, 
with a control group that contains less than half the number of the patient group.
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 Age 
 In large studies and systematic reviews, age has been shown to be a predictor of postop-
erative cognitive dysfunction after noncardiac surgery  [56, 57] . For CAS and CEA, it was also 
shown that increasing age may raise the risk of cognitive decline  [51, 58] , though not all 
studies found a clear effect of age on cognition in CAS  [47, 48, 52, 54] .
 Wasser et al.  [20] found that older patients seem to be particularly vulnerable to cognitive 
decline after CEA, while CAS seems to have better results at follow-up. Feliziani et al.  [24] , 
however, did not find these differences between CEA and CAS in elderly patients. In addition, 
increased neurological complications occur in the elderly after CAS in comparison to CEA, 
hence a patient-tailored approach is mandatory to reduce stroke and death risk in this high-
risk group  [8, 59] .
 Perioperative Embolization 
 CAS has a higher incidence of perioperative microemboli detected by transcranial Doppler 
monitoring compared with CEA, despite the use of distal protection devices  [60–62] . Crawley 
et al.  [60] , however, found no correlation between the amount of emboli of CAS and CEA with 
neuropsychological measures. Martin et al.  [63] concluded in their systematic review that the 
effect of perioperative embolization on cognition remains undecided. This may be the conse-
quence of the variability in type (gaseous vs. particulate) and size of emboli. 
 A few particulate emboli can be more damaging than several gaseous emboli. Therefore, 
differentiation between emboli may be valuable, but even the EmboDop created to differen-
tiate between gaseous and particulate emboli seems up till now unreliable  [64, 65] .
 Transfemoral proximal protection using flow occlusion is increasingly used to protect 
the brain from cerebral embolization during CAS by blocking or reversing the direction of 
blood flow in the distal carotid artery  [54] . In transcervical stenting with flow reversal it is 
possible to eliminate the shower of emboli typically seen in CAS with or without distal 
protection devices  [66] . A recent study  [62] compared CAS with flow reversal to CAS with a 
distal protection device and found lower embolization rates for flow reversal, especially 
during the protection phase of the procedure, though this difference was statistically not 
significant.
 New Brain Lesions after Revascularization 
 As Schnaudigel et al.  [61] showed in their systematic review, CAS is more frequently asso-
ciated with new DWI lesions compared with CEA (37 vs. 10%). These findings were supported 
by several recent studies  [12, 21, 22, 25] . In a randomized trial, Bonati et al.  [11] also found 
that three times more patients in the CAS group than in the CEA group had new ischemic 
lesions (DWI) on post-treatment scans. Schnaudigel et al.  [61] concluded that the use of 
cerebral protection devices (33 vs. 45% without) and closed-cell designed stents during CAS 
(31 vs. 51% with open-cell stents), as well as selective versus routine shunt usage during CEA 
(6 vs. 16%, respectively) also significantly reduced the incidence of new ipsilateral DWI 
lesions.
 Remarkably, numerous studies have failed to find an association between the incidence, 
the number, and the volume of new lesions and changes in cognition for CAS as well as CEA 
 [21, 31, 38, 41, 44, 48, 49, 51] . It seems that DWI does not capture all damage that may evoke 
cognitive deterioration, and some DWI lesions may have little functional value.
 Other Findings Related to Postoperative Changes 
 Using computed tomography perfusion, Cheng et al.  [50] found a close relation between 
the change of perfusion and the change in their cognitive tests. Patients undergoing CAS with 
baseline impairment of middle cerebral artery blood flow were more likely to experience 
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improvement in flow after revascularization. Improvement in middle cerebral artery blood 
flow was associated with greater cognitive improvement in attention and executive func-
tioning  [37] . Repair of a presurgical low relative cerebral blood flow in the ipsilateral cerebral 
hemisphere has been shown to significantly improve postoperative cognitive function in 
patients undergoing CEA  [28, 29] .
 Postoperative cognitive deterioration on the contrary seems significantly associated 
with postoperative hyperperfusion regardless of any new lesions on MRI  [27, 30, 38] . Simi-
larly, cerebral hyperperfusion after CEA results in postoperative cerebral white matter 
damage (detected by diffusion tensor imaging), that is related to postoperative cognitive 
impairment  [30] . The provided data show a link between cognition and postoperative 
perfusion changes for CAS as well as CEA.
 Conclusions 
 In future research, we recommend to include a control group, preferably patients
with asymptomatic carotid stenosis not undergoing revascularization. Although several 
researchers  [37, 42] correctly claim that different forms of material reduce practice effects, 
patients become ‘test wise’. This can also result in significantly increased test scores over time 
 [67] . To avoid alternative explanations, control groups are deemed necessary. Furthermore, 
future research papers should be clear about the exclusion criteria that are essential to 
interpret the results, especially about inclusion and exclusion of stroke patients. On the one 
hand, stroke patients may show better cognitive improvement due to neural reorganization 
that has nothing to do with revascularization. On the other hand, stroke patients could have 
fewer benefits of revascularization due to more permanent brain damage that is not alle-
viated by restored perfusion. When researchers decide to include stroke patients, it is essential 
to check whether stroke has an influence on the postoperative changes in order to rule out 
the fact that these changes are the result of stroke instead of the revascularization. Moreover, 
some researchers use changes in total scores to compare different groups while others 
employ scores in various domains. The latter is advised because some domains may improve 
while others may deteriorate, and a global NCF score may not pick up these subtle differences. 
We recommend to report the percentage of patients in whom NCF improves and in whom 
NCF deteriorates. Finally, in order to reduce the high dropouts of patients during follow-up, 
we advise future researchers to test patients at home or to reduce the frequency and duration 
of the assessments. 
 In this review, we were not able to be strict on features like the type of control group. 
Healthy controls might not be an ideal comparison for patients with carotid artery disease, 
since these two groups are likely to differ on cardiovascular risk factors and general medical 
condition. Comparing carotid interventions to other interventions is a better alternative but 
still leaves possibilities for alternative explanations. An ideal comparison is that of patients 
with significant carotid stenosis undergoing revascularization and similar patients on best 
drug treatment, though for researchers advocating the usefulness of revascularization in 
asymptomatic patients, this may be difficult ethically.
 In comparison with former reviews, we focused on methodological criteria when inter-
preting the results, such as the use of a control group, comprehensive psychometric evalu-
ation (not solely short screening instruments), and assessments not only in the early postop-
erative stage. We can conclude that CEA and CAS have comparable effects on NCF. The incon-
sistency of the various studies has been explained throughout this review article with NCF 
deterioration in 10–15% of CEA patients, while an improvement of 10% of patients was also 
found regularly. Though there are limited methodologically solid studies examining the 
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effects of CAS on cognitive function, the studies provided show similar results. Nonetheless, 
there remains a need for larger, controlled prospective studies assessing NCF after carotid 
revascularization.
 Although NCF following intervention for carotid stenosis remains a matter for debate, it 
is an important outcome measure when comparing different treatments. As stated by Siddiqui 
and Hopkins  [68] and Huang et al.  [69] , postoperative testing should be performed beyond 3 
months to show lasting effects. Especially patients with baseline impaired perfusion could be 
a vulnerable cohort in which revascularization might enhance NCF. 
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